Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Otol Neurotol Open ; 1(2): e004, 2021 Dec.
Article in English | MEDLINE | ID: mdl-38550356

ABSTRACT

Objective: To evaluate whether augmented reality microscopy surgical fluorescence technology, already Food and Drug Administration approved for vascular neurosurgery, can aid in lateral skull base surgery during cerebellopontine (CPA) tumor resection and microvascular decompression. Study Design: Pilot prospective uncontrolled observational cohort study. Setting: An academic tertiary care hospital. Patients: Those who underwent retrosigmoid craniotomy for CPA tumor resection or microvascular decompression for hemifacial spasm, trigeminal neuralgia or pulsatile tinnitus. 11 patients were recruited: 4 underwent CPA tumor resection and 7 underwent microvascular decompression. Interventions: Augmented reality microscopy with fluorescence imaging was utilized to visualize vascular flow intraoperatively. A postoperative surgeon questionnaire was administered to assess the intraoperative efficacy of this technology. Main Outcome Measures: Efficacy of technology in aiding with CPA tumor resection and microvascular decompression. Results: For all 7 microvascular decompression cases, surgeons agreed that the technology aided in identifying areas where disease was affecting tissues with no cases of vascular occlusion identified. In 3 of the 4 CPA tumor resection cases, surgeons agreed that the technology identified areas of vascular flow within the CPA and the tumor. Vascular patency of the sigmoid-transverse sinus was also confirmed. No significant adverse effects were noted except 1 instance of severe-to-profound sensorineural hearing loss. Conclusions: Our study shows that the augmented reality fluorescence technology works during lateral skull base surgery as it can confirm intraoperative vascular integrity. Our data also suggest that this technology may improve visualization of ambiguous vasculature and blood flow to diseased tissue.

2.
Otol Neurotol ; 41(8): e1073, 2020 09.
Article in English | MEDLINE | ID: mdl-32472917

ABSTRACT

: Microvascular decompression (MVD) is curative treatment for primary Hemifacial Spasm, in cases where a vascular loop impinges on the facial nerve. Surgical techniques for MVD may be extended to MVD of the glossopharyngeal nerve and trigeminal nerve in cases of primary glossopharyngeal neuralgia and trigeminal neuralgia. Stroke is a rare complication of these procedures that may occur during the separation of a vascular loop from nervous tissue, particularly when materials such as Teflon are used to separate the structures. Use of an augmented visualization surgical microscope and in vivo fluorescence provides the opportunity to perform an intraoperative "angiogram" to confirm vascular integrity after decompression and enhanced visualization of complex neurovascular anatomy. We report the first description of this novel approach to microvascular decompression for Hemifacial Spasm.SDC video link: http://links.lww.com/MAO/A998.


Subject(s)
Glossopharyngeal Nerve Diseases , Hemifacial Spasm , Microvascular Decompression Surgery , Trigeminal Neuralgia , Glossopharyngeal Nerve Diseases/surgery , Hemifacial Spasm/surgery , Humans , Treatment Outcome , Trigeminal Nerve , Trigeminal Neuralgia/diagnostic imaging , Trigeminal Neuralgia/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...